Literature DB >> 12522047

Characterization of the humoral immune response to Chlamydia outer membrane protein 2 in chlamydial infection.

I Portig1, J C Goodall, R L Bailey, J S H Gaston.   

Abstract

Detection of antibodies to an outer membrane protein 2 (OMP2) by enzyme-linked immunosorbent assay (ELISA) by using either the Chlamydia trachomatis- or the Chlamydia pneumoniae-specific protein was investigated. OMP2 is an immunodominant antigen giving rise to antibody responses in humans infected with different C. trachomatis serovars (A to C and D to K) or with C. pneumoniae, which could be detected by OMP2 ELISA. OMP2 ELISA is not species specific, but antibody titers were usually higher on the homologous protein. The sensitivity of this assay was high but varied according to the "gold standard" applied. Levels of antibody to C. pneumoniae OMP2 as detected by ELISA seem to return to background or near-background values within a shorter period of time compared to antibodies to C. pneumoniae detected by microimmunofluorescence (MIF), making it more likely that positive results in ELISA reflect recent infection. Thus, OMP2 ELISA has distinct advantages over MIF and commercially available ELISAs and might be a useful tool for the serodiagnosis of chlamydial infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522047      PMCID: PMC145281          DOI: 10.1128/cdli.10.1.103-107.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  24 in total

1.  The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae.

Authors:  Y K Wong; J M Sueur; C H Fall; J Orfila; M E Ward
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

2.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

Review 3.  Epidemiology of Chlamydia pneumoniae in atherosclerosis.

Authors:  P Saikku
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

4.  Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.

Authors:  Corinna Hermann; Kathrin Graf; Annemarie Groh; Eberhard Straube; Thomas Hartung
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

5.  Detection of IgG and IgA antibodies to Chlamydia trachomatis in sera of patients with chlamydial infections: use of immunoblotting and immunoperoxidase assays.

Authors:  N Hanuka; M Glasner; I Sarov
Journal:  Sex Transm Dis       Date:  1988 Apr-Jun       Impact factor: 2.830

6.  Serological response to Chlamydia pneumoniae infection.

Authors:  L A Campbell; C C Kuo; S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR).

Authors:  S Ladany; C M Black; C E Farshy; J M Ossewaarde; R C Barnes
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

8.  Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies.

Authors:  Eric L Marston; Andrea V James; J Todd Parker; John C Hart; Teresa M Brown; Trudy O Messmer; Danny L Jue; Carolyn M Black; George M Carlone; Edwin W Ades; Jacquelyn Sampson
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

9.  Analysis of the human serological response to proteins of Chlamydia trachomatis.

Authors:  W J Newhall; B Batteiger; R B Jones
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

10.  Importance of reinfection in the pathogenesis of trachoma.

Authors:  J T Grayston; S P Wang; L J Yeh; C C Kuo
Journal:  Rev Infect Dis       Date:  1985 Nov-Dec
View more
  7 in total

1.  Defining species-specific immunodominant B cell epitopes for molecular serology of Chlamydia species.

Authors:  K Shamsur Rahman; Erfan U Chowdhury; Anil Poudel; Anke Ruettger; Konrad Sachse; Bernhard Kaltenboeck
Journal:  Clin Vaccine Immunol       Date:  2015-03-11

2.  Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.

Authors:  Anja Weinreich Olsen; Michael Theisen; Dennis Christensen; Frank Follmann; Peter Andersen
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

3.  Performance of Chlamydia trachomatis OmcB Enzyme-Linked Immunosorbent Assay in Serodiagnosis of Chlamydia trachomatis Infection in Women.

Authors:  Kanupriya Gupta; LaDraka' Brown; Rakesh K Bakshi; Christen G Press; Xiaofei Chi; Rachel J Gorwitz; John R Papp; William M Geisler
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

4.  Using recombinant Chlamydia trachomatis OMP2 as antigen in diagnostic ELISA test.

Authors:  Mahdieh Javaherian; Zarin Sharifnia; Robabeh Taheripanah; Mojgan Bandepour; Mohammad Soleimani; Bahram Kazemi
Journal:  Iran J Microbiol       Date:  2014-02

5.  Evaluation of an in silico predicted specific and immunogenic antigen from the OmcB protein for the serodiagnosis of Chlamydia trachomatis infections.

Authors:  Olfa Frikha-Gargouri; Radhouane Gdoura; Abir Znazen; Boutheina Gargouri; Jalel Gargouri; Ahmed Rebai; Adnene Hammami
Journal:  BMC Microbiol       Date:  2008-12-10       Impact factor: 3.605

6.  The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding.

Authors:  Katja Moelleken; Johannes H Hegemann
Journal:  Mol Microbiol       Date:  2007-12-11       Impact factor: 3.501

7.  Seroprevalence of antibodies against Pkn1, a novel potential immunogen, in Chlamydia trachomatis-infected Macaca nemestrina and human patients.

Authors:  Achchhe L Patel; Prashant K Mishra; Divya Sachdev; Uma Chaudhary; Dorothy L Patton; Daman Saluja
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.